Chemotherapy-Induced Peripheral Neuropathy Management Advances

a adăugat un sunet Health

2026-08-13 07:16:53 -

Market OverviewChemotherapy-induced peripheral neuropathy represents one of the most common and dose-limiting toxicities of cancer treatment, affecting up to sixty percent of patients receiving neurotoxic agents including platinum compounds, taxanes, and vinca alkaloids. This iatrogenic nerve damage produces sensory symptoms ranging from mild numbness to debilitating pain, motor weakness...

0 Commentarii 0 Distribuiri 3 Views 0 previzualizare